Report cover image

Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Jun 07, 2022
Length 189 Pages
SKU # GBDT17296563

Description

Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Immunochemistry Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Immunochemistry Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins and therapeutic drugs.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

189 Pages
  • About GlobalData
    • Immunochemistry Analyzers Overview
    • Immunochemistry Analyzers - Pipeline Products by Stage of Development
    • Immunochemistry Analyzers - Pipeline Products by Segment
    • Immunochemistry Analyzers - Pipeline Products by Territory
    • Immunochemistry Analyzers - Pipeline Products by Regulatory Path
    • Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
    • Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
    • Immunochemistry Analyzers - Companies Pipeline Products by Stage of Development
    • Astek Diagnostics Company Overview
    • Atonomics A/S (Inactive) Company Overview
    • Beckman Coulter Inc Company Overview
    • Biosan Medical Ltd Company Overview
    • BioSIMS Company Overview
    • Boditech Med Inc Company Overview
    • Boston University Company Overview
    • BreviTest Technologies LLC Company Overview
    • China Medical Technologies Inc (Inactive) Company Overview
    • ChipCare Corp Company Overview
    • Clearbridge BioLoc Pte Ltd Company Overview
    • Corgenix Medical Corp Company Overview
    • DiaSorin SpA Company Overview
    • Drew Scientific Co Ltd Company Overview
    • Dyamed Biotech Pte Ltd Company Overview
    • Enigma Diagnostics Ltd (Inactive) Company Overview
    • Euroimmun AG Company Overview
    • Firalis SAS Company Overview
    • GenapSys Inc Company Overview
    • Genevo Biosystems Pte Ltd Company Overview
    • Great Basin Scientific Inc. Company Overview
    • HeatFlow Technologies Inc Company Overview
    • Hokkaido University Company Overview
    • Huakang Biomedical Holdings Co Ltd Company Overview
    • Indian Institute of Technology Madras Company Overview
    • Johnson & Johnson Company Overview
    • LabNow Inc (Inactive) Company Overview
    • Lucerna Inc Company Overview
    • Magellan Diagnostics Inc Company Overview
    • MedNostic Technologies, LLC Company Overview
    • Merck Millipore Corp Company Overview
    • Meridian Bioscience Inc Company Overview
    • NanoLab Inc Company Overview
    • Ortho Clinical Diagnostics Holdings Plc Company Overview
    • PerkinElmer Inc Company Overview
    • Protomex Life Sciences Company Overview
    • Randox Laboratories Ltd Company Overview
    • Rapid Diagnostek, Inc. Company Overview
    • Siloam Biosciences, Inc. Company Overview
    • Spectradyne LLC Company Overview
    • Tecan Group Ltd Company Overview
    • The Palo Alto Research Center Company Overview
    • Tyncbest Biotechnology Company Overview
    • University of Illinois at Urbana-Champaign Company Overview
    • University of Michigan Pediatric Device Consortium Company Overview
    • University of South Florida Company Overview
    • University of Southern California Company Overview
    • Virogenomics BioDevelopment Inc Company Overview
    • Xanthostat Diagnostics Inc Company Overview
    • Yunnan Energy International Co Ltd Company Overview
    • May 13, 2022: Siemens to exit Russia over invasion of Ukraine; takes 600m hit
    • May 12, 2022: Siemens Strong operational performance and growth ended March 31, 2022
    • May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
    • May 12, 2022: Siemens Announces Q2 FY 2022 results
    • May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
    • May 11, 2022: IsoPlexis Reports First Quarter 2022 Financial Results
    • May 11, 2022: Babson, BD expand strategic partnership to advance diagnostic blood collection in new care settings
    • May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix
    • May 04, 2022: Ortho Clinical Diagnostics Reports First Quarter 2022 Results
    • May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
    • Apr 29, 2022: BD to Present at the BofA Securities 2022 Healthcare Conference
    • Apr 28, 2022: Novacyt Full year 2021 results and update on growth strategy
    • Apr 25, 2022: EKF Diagnostics Holdings announces Posting of Annual Report & Accounts &Notice of AGM
    • Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference
    • Apr 20, 2022: Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022
    • Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results
    • Apr 12, 2022: Tecan announce Annual General Meeting 2022
    • Apr 12, 2022: BIO-TECHNE and Cygnus Technologies, part of Maravai LifeSciences, introduce new simple plex HEK 293 HCP 3G immunoassay
    • Apr 11, 2022: Thermo Fisher Scientific to Host Investor Day
    • Apr 11, 2022: IsoPlexis Reports Preliminary First Quarter 2022 Revenue, Streamlines Operating Structure to Support Sustainable Growth
    • Apr 07, 2022: Quidel Announces Preliminary Revenue for First Quarter 2022
    • Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference
    • Apr 06, 2022: BioPorto Notice Convening the Annual General Meeting
    • Mar 15, 2022: Tecan closes transformative year with substantial growth in sales and net profit
    • Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
    • Mar 14, 2022: Qiagen Announces 20-f Annual Report Filing for 2021 Results
    • Mar 09, 2022: Bioasis to Attend and Present at Upcoming Industry Conference
    • Mar 01, 2022: Cardiff Oncology to Participate in Cowen's 42nd Annual Healthcare Conference
    • Feb 25, 2022: Bio-Rad presents growth strategy and acceleration of financial targets at investor day
    • Feb 24, 2022: BD to Present at the Cowen 42nd Annual Health Care Conference
    • Feb 23, 2022: embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD
    • Feb 23, 2022: Bd Appoints Shana Neal as Chief People Officer
    • Feb 16, 2022: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results
    • Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
    • Feb 14, 2022: Bio-Rad Laboratories to Post Q1 2022 Earnings of $2.80 Per Share, Jefferies Financial Group Forecasts
    • Feb 14, 2022: Horiba announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2021
    • Feb 11, 2022: KAIST develops rapid bacterial detection method using deep learning
    • Feb 11, 2022: Span Divergent Un-Audited Financial Results for the Quarter Ended 31st December 2021
    • Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
    • Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
    • Feb 02, 2022: Bio-Rad to Host Investor Day on February 25
    • Jan 31, 2022: EKF Diagnostics Holdings Announces Non-executive Directorate Change
    • Jan 27, 2022: Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
    • Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results
    • Jan 11, 2022: Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs
    • Jan 11, 2022: SDI Group Announces Board Change
    • Jan 07, 2022: Quidel Announces Preliminary Revenue for Fourth Quarter 2021
    • Jan 06, 2022: BD Announces Change to Virtual 2022 Annual Meeting of Shareholders
    • Jan 05, 2022: BD to announce financial results for its first quarter of fiscal year 2022
    • Jan 04, 2022: Halo Collective appoints Sky Pinnick as chief marketing officer
    • Jan 03, 2022: Ortho Clinical Diagnostics to Participate in the 40th Annual JP Morgan Healthcare Conference
    • Jan 02, 2022: Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
    • Dec 21, 2021: BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business
    • Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
    • Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference
    • Dec 07, 2021: SDI Group Announces Interim results for the six months ended 31 October 2021
    • Dec 07, 2021: SDI Group - Interim Results for the six months ended 31 October 2021
    • Nov 29, 2021: Bioasis Announces Annual General Meeting Details
    • Nov 26, 2021: Mitsubishi Chemical Holdings Notice of Changes Regarding the Corporate Executive Officer and Chief Financial Officer
    • Nov 23, 2021: EKF Diagnostics Holdings Appoints Marc Davies as Chief Financial Officer
    • Nov 23, 2021: Biolidics Announces Appointment of Independent Director
    • Nov 22, 2021: RD-Biotech expands antibody and immunoassay services with xMAP Technology
    • Nov 15, 2021: BioPorto Announces Extraordinary General Meeting and New Board Member
    • Nov 12, 2021: Psychemedics Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021
    • Nov 11, 2021: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2021
    • Nov 10, 2021: Sysmex announces Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2022
    • Nov 10, 2021: Sysmex Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2021, and Revision of Full-Year Financial Forecasts
    • Nov 04, 2021: Quidel Reports Third Quarter 2021 Financial Results
    • Nov 04, 2021: Cardiff Oncology Reports Third Quarter 2021 Results and Provides Business Updates
    • Oct 29, 2021: Halo Collective announces "Budega" as name for retail store brand, appoints new retail senior vice president
    • Oct 26, 2021: BD to Host Investor Day on November 12
    • Oct 20, 2021: BioPorto appoints new Chief Executive Officer and announces changes to the Board of Directors
    • Oct 20, 2021: BioPorto appoints new Chief Financial Officer
    • Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
    • Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
    • Oct 12, 2021: Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021
    • Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference
    • Oct 07, 2021: Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021
    • Oct 01, 2021: Mitsubishi Chemical Holdings announces Personnel Personnel Changes
    • Sep 30, 2021: Bioasis to Attend Upcoming Industry Conferences
    • Sep 29, 2021: Novacyt Announces Annual General Meeting
    • Sep 29, 2021: Novacyt Notice of AGM
    • Sep 27, 2021: Novacyt reports 1H results
    • Sep 27, 2021: Novacyt Announces unaudited results for the half year ended 30 June 2021
    • Sep 16, 2021: Lynette Jackson appointed as new head of communications at Siemens
    • Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    • Sep 14, 2021: EKF Diagnostics Holdings Announces unaudited interim results for the six months ended 30 June 2021
    • Sep 13, 2021: SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
    • Sep 03, 2021: Ortho Clinical Diagnostics to Participate in September Investor Conferences
    • Sep 02, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
    • Sep 01, 2021: BioMerieux announce First-Half 2021 Results
    • Sep 01, 2021: Biolidics Announces Re-designation of Interim Chief Executive Officer as Chief Scientific Officer
    • Sep 01, 2021: Biolidics Appointment of Director of Corporate Finance and Corporate Development
    • Sep 01, 2021: Biolidics Announces Appointment of Executive Director and Chief Executive Officer
    • Aug 23, 2021: SDI Group Posting of Annual Report and Notice of AGM
    • Aug 20, 2021: Novacyt Notice of AGM
    • Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
    • Aug 18, 2021: BioPorto Announces Q2 2021 Report
    • Aug 16, 2021: Halo Collective releases Q2 2021 results
    • Aug 13, 2021: Biolidics' Revenue Dipped to S$0.64 Million in the First Half of 2021
    • Aug 13, 2021: A multiplex TaqMan qPCR assay for detection and quantification of clade 1 and clade 2 isolates of Pseudoperonospora cubensis and Pseudoperonospora humuli
    • Aug 13, 2021: A novel multiplex qPCR method for assessing the comparative lengths of telomeres
    • Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
    • Aug 11, 2021: Span Divergent announces Result For The Quarter Ended On June 30, 2021
    • Aug 10, 2021: Horiba Reports Consolidated Financial Statements for the Six Months Ended June 30, 2021
    • Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual
    • Aug 06, 2021: Sysmex Provides Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2022
    • Aug 05, 2021: Siemens Announces Excellent Results with Raised Guidance
    • Aug 04, 2021: Ortho Clinical Diagnostics Reports Second Quarter 2021 Results
    • Aug 04, 2021: Mitsubishi Chemical Holdings announces Financial Results Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022
    • Aug 04, 2021: Mitsubishi Chemical Holdings Announces Notice Regarding Revision to Consolidated Financial Results Forecast for the First Half of Fiscal Year Ending March 31, 2022
    • Jul 29, 2021: Bio-Rad Reports Second-Quarter 2021 Financial Results
    • Jul 29, 2021: QIAGEN Reports Full Results for Q2 and H1 2021
    • Jul 29, 2021: BD to Present at UBS Genomics 2.0 and MedTech Innovations Summit
    • Jul 29, 2021: Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A
    • Jul 28, 2021: Hologic Announces Financial Results for Third Quarter of Fiscal 2021
    • Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference
    • Jul 23, 2021: Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021
    • Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results
    • Jul 19, 2021: Theradiag Reports Revenue of 5.5 Million for the First Half of 2021, Up 12.5%
    • Jul 01, 2021: Bioasis Announces the Appointment of Dave Jenkins as Chief Financial Officer
    • Jun 24, 2021: Mitsubishi Chemical Holdings announces Personnel Notice Regarding Executive Personnel Changes
    • Jun 23, 2021: Halo Collective Announces Results of Annual General and Special Meeting
    • Jun 22, 2021: Novacyt Full Year 2020 Results and Update on Growth Strategy
    • Jun 22, 2021: Novacyt Announces Full year 2020 results and update on growth strategy
    • Jun 16, 2021: Mitsubishi Chemical Announces Personnel Organizational Changes and Personnel Changes
    • Jun 14, 2021: Biolidics Announces Appointment of Ian David Brown as an Independent Director
    • Jun 11, 2021: Span Divergent announces Financial Results For The Year Ended On March 31, 2021
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.